Finding studies
Finding studies
Take this into the appointment.
Saves the questions and what to expect into your notes, next to the visit they belong to.
Aiqin Gu, MD
CONTACT
Lead
Shanghai Chest Hospital
With
Explore blood exosomal miRNA as a biomarker for predicting the efficacy or risk of serious adverse reactions in patients with advanced lung adenocarcinoma (or lung squamous cell carcinoma) after anlotinib treatment.
Age
18–75
Sex
ALL
Healthy volunteers
Not accepted
